Guska took part in BioSpain, a leading biotechnology event in Spain that brings together key players from across the sector.
Attending on behalf of the company were Nicolás Bordería (CEO of Guska), Antonio Bordería (Senior Business Advisor), and Juan Gandioli (researcher at the startup).
“During BioSpain, we met with investors specialized in therapeutic developments to better understand what they look for in startups like Guska. We also met with biotechnology innovation hubs to explore how they can help boost a company like ours. In addition, we held meetings with consultants specializing in oncolytic virotherapies to continue strengthening our development strategy,” explained Tambucho.
“Overall, it was a great opportunity to build connections, identify new trends, and continue positioning Guska internationally,” he added.
Guska develops oncolytic viruses designed to attack cancer cells without harming healthy ones.
